By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Tissue supply firm Asterand today said that its BioSeek subsidiary will provide its BioMap predictive human disease models to Cellzome for use in its inflammatory disease drug discovery projects.

The BioMap platform will be used to predict possible human clinical responses to small molecules identified by Cellzome using its own Kinobeads and Episphere screening and profiling technologies. The agreement is for two years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: GWAS links gene to noise-induced hearing loss in mice, population genetics of malaria parasites, and more.

Nautilus' Alexandra Ossola examines how Tay-Sachs disease jump-started the genetic disease testing field.

FASEB says guidelines proposed by the NIH to bolster research reproducibility are premature and don't take the full range of scientific studies into consideration.

Liquid biopsies and DNA tests may be able to tell physicians whether a cancer patient is relapsing, the New York Times reports.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.